COCRYSTAL PHARMA INC (COCP) Stock Income Statement
NASDAQ:COCP - US19188J4094 - Common Stock
1.5 USD
-0.07 (-4.46%)
1.5 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 12.72M | 18.00M | 21.60M | 18.14M | 14.22M | |||
| Research and Development | 7.76M | N/A | 15.17M | 12.39M | 8.79M | |||
| Selling, General, and Administrative Expenses | 4.96M | 5.34M | 5.99M | 5.75M | 5.43M | |||
| Operating Income | -12.72M | -18.00M | -21.60M | -18.14M | -14.22M | |||
| Interest Income/Expense | 160.00K | N/A | 575.00K | -10.00K | 40.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 2.60M | -20.69M | N/A | |||
| Income Before Taxes | -12.56M | -18.00M | -18.00M | -38.84M | -14.19M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -12.56M | -18.00M | -18.00M | -38.84M | -14.19M | |||
| EBITDA | -12.62M | -17.87M | -21.41M | -17.95M | -14.03M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.24 | -1.80 | -1.86 | -4.77 | -1.93 | |||
| Non GAAP EPS | -1.24 | -1.73 | -1.90 | -4.73 | -1.92 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD